HomeDMN • FRA
add
Diamyd Medical AB
Nakaraang pagsara
€0.14
Sakop ng araw
€0.092 - €0.092
Sakop ng taon
€0.090 - €1.80
Market cap
190.64M SEK
Average na Volume
1.63K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (SEK) | Peb 2026info | Y/Y na pagbabago |
|---|---|---|
Kita | 99.00K | 15.12% |
Gastos sa pagpapatakbo | 64.34M | 43.95% |
Net na kita | -62.88M | -40.14% |
Net profit margin | -63.51K | -21.74% |
Kita sa bawat share | — | — |
EBITDA | -63.24M | -43.70% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (SEK) | Peb 2026info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 190.73M | 83.83% |
Kabuuang asset | 253.63M | 40.22% |
Kabuuang sagutin | 83.84M | 20.89% |
Kabuuang equity | 169.80M | — |
Natitirang share | 137.50M | — |
Presyo para makapag-book | 0.12 | — |
Return on assets | -58.47% | — |
Return on capital | -80.99% | — |
Cash Flow
Net change in cash
| (SEK) | Peb 2026info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -62.88M | -40.14% |
Cash mula sa mga operasyon | -39.51M | 18.40% |
Cash mula sa pag-invest | -20.11M | -4,291.05% |
Cash mula sa financing | -2.14M | -237.01% |
Net change in cash | -62.39M | -27.00% |
Malayang cash flow | -19.53M | 40.32% |
Tungkol
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Itinatag
1984
Website
Mga Empleyado
41
